Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
- PMID: 25982811
- DOI: 10.1016/j.schres.2015.04.040
Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome
Abstract
Negative symptoms, in particular motivational deficits, are reported as impediments to functional recovery in patients with schizophrenia. This study examined the prevalence of motivational deficits in patients early in the illness, and the impact these deficits have on community functioning. Patients with schizophrenia between the ages of 18 and 35years, and within 5years of initiating antipsychotic treatment were included in the present investigation (N=166). The impact of motivation and cognition on concurrent and longitudinal functioning was evaluated. Motivational impairments were found in more than 75% of participants, and were not associated with receipt of social support. These deficits served as the most robust and reliable predictor of functional outcome, while neurocognition demonstrated significantly weaker associations with outcome. When considered together, motivational deficits demonstrated a reliable link with concurrent and longitudinal functioning, with cognition not offering any independent predictive value. Moreover, motivation was found to mediate the relationship between cognition and outcome. Changes in motivation were linked to changes in functioning; however, this was not the case for changes in cognitive performance. Motivation emerged as a significant predictor of functioning even after selected demographic and clinical characteristics (e.g., positive symptoms) were accounted for. These data indicate that motivational deficits are prevalent in patients with schizophrenia, even in the early stages of the illness, and these deficits stand as one of the most robust barriers to people with schizophrenia achieving functional recovery. Greater understanding of the mechanisms underlying these deficits is critical to effective treatment innovation.
Keywords: Amotivation; Apathy; Avolition; Negative symptoms; Neurocognition; Psychosis; Real-world functional outcome; Social functioning.
Copyright © 2015 Elsevier B.V. All rights reserved.
Similar articles
-
Motivational deficits and cognitive test performance in schizophrenia.JAMA Psychiatry. 2014 Sep;71(9):1058-65. doi: 10.1001/jamapsychiatry.2014.1105. JAMA Psychiatry. 2014. PMID: 25075930 Clinical Trial.
-
Motivational and neurocognitive deficits are central to the prediction of longitudinal functional outcome in schizophrenia.Acta Psychiatr Scand. 2014 Oct;130(4):290-9. doi: 10.1111/acps.12289. Epub 2014 May 22. Acta Psychiatr Scand. 2014. PMID: 24850369
-
Impact of avolition and cognitive impairment on functional outcome in first-episode schizophrenia-spectrum disorder: a prospective one-year follow-up study.Schizophr Res. 2016 Feb;170(2-3):318-21. doi: 10.1016/j.schres.2016.01.004. Epub 2016 Jan 9. Schizophr Res. 2016. PMID: 26778673
-
[Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].Encephale. 2013 May;39 Suppl 1:S64-71. doi: 10.1016/j.encep.2012.10.011. Epub 2013 Mar 23. Encephale. 2013. PMID: 23528322 Review. French.
-
Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders.Eur Neuropsychopharmacol. 2014 May;24(5):693-709. doi: 10.1016/j.euroneuro.2013.10.017. Epub 2013 Nov 11. Eur Neuropsychopharmacol. 2014. PMID: 24275699 Review.
Cited by
-
Diverse definitions of the early course of schizophrenia-a targeted literature review.NPJ Schizophr. 2018 Oct 15;4(1):21. doi: 10.1038/s41537-018-0063-7. NPJ Schizophr. 2018. PMID: 30323274 Free PMC article. Review.
-
Reliability and Replicability of Implicit and Explicit Reinforcement Learning Paradigms in People With Psychotic Disorders.Schizophr Bull. 2021 Apr 29;47(3):731-739. doi: 10.1093/schbul/sbaa165. Schizophr Bull. 2021. PMID: 33914891 Free PMC article.
-
Motivation and Pleasure Domain Links to Social Function in College Students: A Network Analysis.Psych J. 2025 Aug;14(4):534-544. doi: 10.1002/pchj.70001. Epub 2025 Feb 24. Psych J. 2025. PMID: 39993927 Free PMC article.
-
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.Lipids Health Dis. 2020 Jul 3;19(1):159. doi: 10.1186/s12944-020-01337-0. Lipids Health Dis. 2020. PMID: 32620164 Free PMC article. Review.
-
Residual experiential symptoms mediate the effect of expressive symptoms over the social functioning in remitted schizophrenia.Ind Psychiatry J. 2023 Jul-Dec;32(2):309-316. doi: 10.4103/ipj.ipj_30_23. Epub 2023 Aug 31. Ind Psychiatry J. 2023. PMID: 38161473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical